CrystalGenomics Inc (083790) — Cash Flow-to-Debt Ratio
CrystalGenomics Inc (083790) has a Cash Flow-to-Debt Ratio of -0.09x as of September 2025, meaning its operating cash flow of ₩-11.39 Billion could theoretically repay 0% of its total liabilities (₩124.24 Billion) in one year. See 083790 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
CrystalGenomics Inc Cash Flow-to-Debt Ratio (2014–2024)
Historical debt coverage capacity for CrystalGenomics Inc across 11 annual periods. For the full cash flow conversion analysis, see CrystalGenomics Inc cash flow conversion.
Annual Cash Flow-to-Debt Ratio for CrystalGenomics Inc (2014–2024)
Year-by-year debt coverage analysis for CrystalGenomics Inc. Check CrystalGenomics Inc (083790) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.16x | ₩-25.85 Billion | ₩161.95 Billion | ▲ +51.8% |
| 2023 | -0.33x | ₩-32.41 Billion | ₩97.82 Billion | ▼ -82.4% |
| 2022 | -0.18x | ₩-24.40 Billion | ₩134.34 Billion | ▼ -98.3% |
| 2021 | -0.09x | ₩-11.46 Billion | ₩125.09 Billion | ▲ +42.9% |
| 2020 | -0.16x | ₩-16.38 Billion | ₩102.20 Billion | ▼ -416.9% |
| 2019 | -0.03x | ₩-7.14 Billion | ₩230.14 Billion | ▼ -86.2% |
| 2018 | -0.02x | ₩-1.21 Billion | ₩72.45 Billion | ▼ -128.4% |
| 2017 | 0.06x | ₩1.63 Billion | ₩27.88 Billion | ▲ +132.1% |
| 2016 | -0.18x | ₩-8.30 Billion | ₩45.51 Billion | ▼ -113.6% |
| 2015 | -0.09x | ₩-4.73 Billion | ₩55.34 Billion | ▼ -16.1% |
| 2014 | -0.07x | ₩-3.75 Billion | ₩51.02 Billion | — |